...
首页> 外文期刊>Journal of general internal medicine >Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors.
【24h】

Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors.

机译:在无症状的2型糖尿病和其他动脉粥样硬化危险因素中筛查冠状动脉疾病的成本效益。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Screening for coronary artery disease (CAD) in asymptomatic diabetic patients with two additional atherogenic risk factors has been recommended by the American College of Cardiology/American Diabetes Association, but its cost-effectiveness is yet to be determined. The present study aims to evaluate the cost-effectiveness of screening and determine acceptable strategies. DESIGN: Cost-effectiveness analysis using a Markov model was performed from a societal perspective to measure the clinical benefit and economic consequences of CAD screening in asymptomatic men with diabetes and two additional atherogenic risk factors. We evaluated cohorts of patients stratified by different age groups, and 10 possible combination pairs of atherogenic risks. Incremental cost-effectiveness of no screening, exercise electrocardiography, exercise echocardiography, or exercise single-photon emission-tomography (SPECT) was calculated. Input data were obtained from the published literature. Outcomes were expressed as U.S. dollars per quality-adjusted life-year (QALY). MEASUREMENTS AND MAIN RESULTS: Compared with no screening, incremental cost-effectiveness ratio of exercise electrocardiography was Dollars 41,600/QALY in 60-year-old asymptomatic diabetic men with hypertension and smoking, but was weakly dominated by exercise echocardiography. Exercise echocardiography was most cost-effective, with an incremental cost-effectiveness ratio of Dollars 40,800/QALY. Exercise SPECT was dominated by other strategies. Sensitivity analyses found that results varied depending on age, combination of additional atherogenic risk factors, and diagnostic test performance. CONCLUSIONS: Incremental cost-effectiveness ratio of CAD screening in asymptomatic patients with diabetes and two or more additional atherogenic risk factors is shown to be acceptable from a societal perspective. Exercise echocardiography was the most cost-effective strategy, followed by exercise electrocardiography.
机译:目的:美国心脏病学会/美国糖尿病协会已建议筛查无症状糖尿病患者并伴有另外两个致动脉粥样硬化危险因素的冠状动脉疾病(CAD),但其成本效益尚待确定。本研究旨在评估筛查的成本效益并确定可接受的策略。设计:从社会角度使用马尔可夫模型进行了成本效益分析,以评估无症状糖尿病和另外两个动脉粥样硬化危险因素的CAD筛查的临床获益和经济后果。我们评估了按年龄段分层的患者队列,以及10种可能的成对动脉粥样硬化风险组合。计算了不进行筛查,运动心电图,运动超声心动图或运动单光子发射断层扫描(SPECT)的增量成本效益。输入数据来自已发表的文献。结果表示为每质量调整生命年(QALY)的美元。测量和主要结果:与不进行筛查相比,运动心电图对60岁无症状高血压和吸烟的糖尿病男子的增加的成本-效果比为41,600美元/ QALY,但在运动超声心动图检查中占主导地位。运动超声心动图是最具成本效益的,成本效益比增加了40,800美元/ QALY。锻炼SPECT受其他策略支配。敏感性分析发现,结果因年龄,其他致动脉粥样硬化危险因素的组合以及诊断测试的性能而异。结论:从社会的角度来看,无症状糖尿病和两个或多个其他动脉粥样硬化危险因素的CAD筛查的成本效益比增加是可以接受的。运动超声心动图是最具成本效益的策略,其次是运动心电图。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号